Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.
about
Suppression of APOBEC3-mediated restriction of HIV-1 by VifThe Road Less Traveled: HIV's Use of Alternative Routes through Cellular PathwaysAPOBEC3 Interference during Replication of Viral GenomesCyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase MachineryHIV restriction by APOBEC3 in humanized mice.Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.Lack of mutational hot spots during decitabine-mediated HIV-1 mutagenesisA small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2.A multi-scale mathematical modeling framework to investigate anti-viral therapeutic opportunities in targeting HIV-1 accessory proteins.Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif proteinHost restriction factors in retroviral infection: promises in virus-host interaction.HIV-1 viral infectivity factor (Vif) alters processive single-stranded DNA scanning of the retroviral restriction factor APOBEC3GSupT1 Cell Infusion as a Possible Cell-Based Therapy for HIV: Results from a Pilot Study in Hu-PBMC BRGS Mice.Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.HIV accessory proteins versus host restriction factors.Herb-target interaction network analysis helps to disclose molecular mechanism of traditional Chinese medicine.Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention.CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.Is a pacific coexistence between virus and host the unexploited path that may lead to an HIV functional cure?Design, synthesis and biological evaluation of indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors.5-Azacytidine Enhances the Mutagenesis of HIV-1 by Reduction to 5-Aza-2'-Deoxycytidine.Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition.Indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors.Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin.APOBEC Enzymes as Targets for Virus and Cancer Therapy.Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.An improved method for purification and refolding of recombinant HIV Vif expressed in Escherichia coli.Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation.
P2860
Q27025150-9C0B1791-CB97-4935-828C-3E5D84D8613EQ27027607-9EE9918C-B000-4BED-BE1A-A56CF239E501Q28081195-39F4E44A-6C55-444C-86DB-559B4552368FQ33567848-AE24421B-20D4-43E4-B235-4E03B0C9748DQ34649651-CB102474-BDF4-49F8-A6F4-07750D4DD8B2Q35451347-05D63CE6-A368-4B8A-BC29-C79C97E6739AQ35682519-520B9956-AB70-42EF-9BC0-FB86F8FEDC54Q36158234-A27A0BA1-E125-44ED-9141-442838D4ACB9Q36376142-EF7DB9AC-F25F-44AB-B77C-9F18F0DF161DQ36387986-432BF2DC-2981-4E66-8DA2-E70C4E3E7D31Q36432758-EE70DDA7-2631-4C61-A011-388A47AADC4CQ36548179-7AE9960B-51A7-49AB-B17C-EAEA21B02CBCQ36647213-6AD81861-E0CA-4B38-80D3-2D6A39FA3D0DQ37061926-E856DC3E-86F1-4E9D-8A70-DEED7B89AF9DQ37153444-F857E85C-ECA4-45DC-8FA9-39C3F43AD0F4Q37375080-8484164F-A19F-462E-9085-6B010EC76A7FQ37408417-03541B47-E08D-4AF7-8985-0A0250F0BF22Q38052946-1A9C8A88-AC38-4382-B5BF-DDD6CBE928E6Q38377965-3C8C5549-7AE3-4B5F-B0D8-52EB0C954B8CQ39190552-7E6596E3-5B3A-47BD-8DA7-9E99699E9A67Q39200129-2257B4B3-32F1-45A7-BE9A-C4691245F70CQ39514817-0878005B-CB29-42D5-8DA7-BB51808A9D86Q41609219-0F9606E9-77A3-40F4-BF28-7CF77B9F797AQ42712951-290CDD6C-D335-4531-9083-6BB565D868A3Q43433320-C58768DD-CAEA-42B2-81C0-EF951ECDBA2BQ45324625-0D76DE61-80DD-4B73-AD11-BBBA545420BCQ47135036-41F17B4C-99EB-4271-BA0F-50722B83FA7BQ51011655-0EDA6521-3E00-410A-90B3-E551E603AEFEQ55380693-E01285C3-EB58-4C25-8792-0D3C439BFC07
P2860
Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Small-molecule inhibition of h ...... tion between Vif and ElonginC.
@ast
Small-molecule inhibition of h ...... tion between Vif and ElonginC.
@en
Small-molecule inhibition of h ...... tion between Vif and ElonginC.
@nl
type
label
Small-molecule inhibition of h ...... tion between Vif and ElonginC.
@ast
Small-molecule inhibition of h ...... tion between Vif and ElonginC.
@en
Small-molecule inhibition of h ...... tion between Vif and ElonginC.
@nl
prefLabel
Small-molecule inhibition of h ...... tion between Vif and ElonginC.
@ast
Small-molecule inhibition of h ...... tion between Vif and ElonginC.
@en
Small-molecule inhibition of h ...... tion between Vif and ElonginC.
@nl
P2093
P2860
P356
P1433
P1476
Small-molecule inhibition of h ...... tion between Vif and ElonginC.
@en
P2093
Donglai Liu
Haihong Zhang
Hongwei Jin
Jiawen Wang
Liangren Zhang
P2860
P304
P356
10.1128/JVI.06957-11
P407
P577
2012-02-29T00:00:00Z